[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PT1294729E - 2-aminoalquil-tieno[2,3-d]pirimidinas - Google Patents

2-aminoalquil-tieno[2,3-d]pirimidinas

Info

Publication number
PT1294729E
PT1294729E PT01965045T PT01965045T PT1294729E PT 1294729 E PT1294729 E PT 1294729E PT 01965045 T PT01965045 T PT 01965045T PT 01965045 T PT01965045 T PT 01965045T PT 1294729 E PT1294729 E PT 1294729E
Authority
PT
Portugal
Prior art keywords
sup
pyrimidines
aminoalquil
tiene
treatment
Prior art date
Application number
PT01965045T
Other languages
English (en)
Inventor
Maria Christadler
Norbert Beier
Rochus Jonas
Schelling Pierre
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PT1294729E publication Critical patent/PT1294729E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT01965045T 2000-06-29 2001-06-28 2-aminoalquil-tieno[2,3-d]pirimidinas PT1294729E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10031585A DE10031585A1 (de) 2000-06-29 2000-06-29 2-Aminoalkyl-thieno[2,3-d]pyrimidine

Publications (1)

Publication Number Publication Date
PT1294729E true PT1294729E (pt) 2005-01-31

Family

ID=7647152

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01965045T PT1294729E (pt) 2000-06-29 2001-06-28 2-aminoalquil-tieno[2,3-d]pirimidinas

Country Status (23)

Country Link
US (1) US7259168B2 (pt)
EP (1) EP1294729B1 (pt)
JP (1) JP2004501925A (pt)
KR (1) KR20030010756A (pt)
CN (1) CN1234712C (pt)
AR (1) AR031856A1 (pt)
AT (1) ATE276260T1 (pt)
AU (2) AU2001285785B2 (pt)
BR (1) BR0112092A (pt)
CA (1) CA2410408C (pt)
CZ (1) CZ20024070A3 (pt)
DE (2) DE10031585A1 (pt)
DK (1) DK1294729T3 (pt)
ES (1) ES2227259T3 (pt)
HU (1) HUP0301466A3 (pt)
MX (1) MXPA02012260A (pt)
NO (1) NO20026246L (pt)
PL (1) PL358552A1 (pt)
PT (1) PT1294729E (pt)
RU (1) RU2261863C2 (pt)
SK (1) SK17822002A3 (pt)
WO (1) WO2002000664A1 (pt)
ZA (1) ZA200209729B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10031585A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-Aminoalkyl-thieno[2,3-d]pyrimidine
AR090037A1 (es) * 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
CA2903176A1 (en) 2013-03-14 2014-09-18 Novartis Ag 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
CN108135906A (zh) * 2015-07-24 2018-06-08 路易斯维尔大学研究基金会有限公司 治病化合物、组合物、方法、及化合物制备方法
ES2968822T3 (es) * 2017-12-15 2024-05-14 Union Therapeutics As Azetidina dihidrotienopirimidinas sustituidas y su uso como inhibidores de la fosfodiesterasa

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19632423A1 (de) * 1996-08-12 1998-02-19 Merck Patent Gmbh Thienopyrimidine
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19752952A1 (de) * 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine
DE19819023A1 (de) * 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
DE19928146A1 (de) * 1999-06-19 2000-12-21 Merck Patent Gmbh Thienopyrimidine
DE10010612A1 (de) * 2000-03-03 2001-09-27 Merck Patent Gmbh Verwendung von PDE V-Inhibitoren
DE10031585A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-Aminoalkyl-thieno[2,3-d]pyrimidine
DE10031584A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
TWI447508B (zh) 2010-04-01 2014-08-01 Delta Electronics Inc 投影裝置以及用於判斷一光點於投影畫面之位置之定位方法

Also Published As

Publication number Publication date
CN1439012A (zh) 2003-08-27
JP2004501925A (ja) 2004-01-22
HUP0301466A2 (hu) 2003-11-28
CN1234712C (zh) 2006-01-04
BR0112092A (pt) 2003-05-06
DK1294729T3 (da) 2005-01-17
ES2227259T3 (es) 2005-04-01
PL358552A1 (en) 2004-08-09
HUP0301466A3 (en) 2005-04-28
AU2001285785B2 (en) 2006-04-13
MXPA02012260A (es) 2003-04-25
RU2261863C2 (ru) 2005-10-10
CA2410408C (en) 2010-06-22
NO20026246D0 (no) 2002-12-27
ATE276260T1 (de) 2004-10-15
WO2002000664A1 (de) 2002-01-03
US20040044011A1 (en) 2004-03-04
CA2410408A1 (en) 2002-11-26
EP1294729A1 (de) 2003-03-26
AU8578501A (en) 2002-01-08
ZA200209729B (en) 2004-03-08
AR031856A1 (es) 2003-10-08
US7259168B2 (en) 2007-08-21
DE10031585A1 (de) 2002-01-10
EP1294729B1 (de) 2004-09-15
DE50103649D1 (de) 2004-10-21
KR20030010756A (ko) 2003-02-05
NO20026246L (no) 2002-12-27
CZ20024070A3 (cs) 2003-04-16
SK17822002A3 (sk) 2003-05-02

Similar Documents

Publication Publication Date Title
AU3652102A (en) Compounds and their uses
BG106406A (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors
TR200400702T4 (tr) AMP özgü fosfodiesteraz inhibtörleri olarak 3-tiazol-4-il-pirolidin türevleri.
MY132106A (en) New pyridazin-3(2h)-one derivatives
BG106585A (en) Kinase inhibitors as therapeutic agents
DK1480961T3 (da) Glutaminylbaserede DPIV-inhibitorer
BG103964A (en) SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS
MXPA03009750A (es) Compuestos quimicos.
WO2002085906A3 (en) Phthalazinones derivatives useful as pde4/7 inhibitors
EP1140900A4 (en) PYRAZOLE COMPOUNDS AND USE OF SUCH COMPOUNDS
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
AU1182702A (en) Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
DE50211929D1 (en) Pyrimidinderivate
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
MXPA02012263A (es) 5-aminoalquil-pirazol[4,3-d]pirimidinas.
BR0109512A (pt) Imidazopiridinas tricìclicas
HK1056725A1 (en) 2-Thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry.
WO2002051848A3 (de) Sulfamidothienopyrimidine zur verwendung als phosphodiesterase v-hemmer
UY26426A1 (es) Nuevos compuestos
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
DE60202669D1 (de) 6-phenylbenzonaphthyidine
PT1294729E (pt) 2-aminoalquil-tieno[2,3-d]pirimidinas
DE60204882D1 (de) Zykloalkenylsulfonamidderivate
AP2002002417A0 (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors.
UA80871C2 (en) 5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension